Cargando…

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

BACKGROUND: The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA) is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and autoantibodies could be involved in the pathogenesis of atherosclerotic disease. It has been suggested that anti-phosphory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ajeganova, Sofia, Andersson, Maria L. E., Frostegård, Johan, Hafström, Ingiäld
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314464/ https://www.ncbi.nlm.nih.gov/pubmed/34311770 http://dx.doi.org/10.1186/s13075-021-02581-0

Ejemplares similares

Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years
por: Ajeganova, Sofia, et al.
Publicado: (2021)

Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms
por: Frostegård, Johan, et al.
Publicado: (2021)

Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study
por: Elkan, Ann-Charlotte, et al.
Publicado: (2009)

Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients
por: Ajeganova, Sofia, et al.
Publicado: (2020)

Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study
por: Elkan, Ann-Charlotte, et al.
Publicado: (2008)

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial
por: Ajeganova, Sofia, et al.
Publicado: (2014)

Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study
por: Ajeganova, Sofia, et al.
Publicado: (2015)

Anti-citrullinated protein antibodies are associated with osteopenia but not with pain at diagnosis of rheumatoid arthritis: data from the BARFOT cohort
por: Hafström, Ingiäld, et al.
Publicado: (2019)

Erosion-free rheumatoid arthritis: clinical and conceptional implications—a BARFOT study
por: Svensson, Björn, et al.
Publicado: (2022)

Misdiagnosis of Rheumatoid Arthritis in a Long-Term Cohort of Early Arthritis Based on the ACR-1987 Classification Criteria
por: Leu Agelii, Monica, et al.
Publicado: (2022)

Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years
por: Ajeganova, Sofia, et al.
Publicado: (2023)

Influence of Age and Sex on Disease Course and Treatment in Rheumatoid Arthritis
por: Nilsson, Jenny, et al.
Publicado: (2021)

Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass - a cross sectional study
por: Elkan, Ann-Charlotte, et al.
Publicado: (2011)

A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis – results of clinical relevance
por: Hafström, Ingiäld, et al.
Publicado: (2019)

Effects of Atorvastatin on T‐Cell Activation and Apoptosis in Systemic Lupus Erythematosus and Novel Simulated Interactions With C‐Reactive Protein and Interleukin 6
por: Sun, Jitong, et al.
Publicado: (2021)

Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis – A BARFOT Study
por: Andersson, Maria L.E, et al.
Publicado: (2015)

Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
por: Frostegård, Johan
Publicado: (2023)

The association between diet and glucocorticoid treatment in patients with SLE
por: Lourdudoss, Cecilia, et al.
Publicado: (2016)

Does digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis?
por: Forslind, Kristina, et al.
Publicado: (2012)

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria
por: Svensson, Björn, et al.
Publicado: (2013)

Reported disability in relation to observed activity limitation, grip strength and physical function in women and men with rheumatoid arthritis
por: Bala, Sidona-Valentina, et al.
Publicado: (2021)

Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014)

Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
por: Hafström, Ingiäld, et al.
Publicado: (2014)

Widespread pain and pain intensity in patients with early rheumatoid arthritis. A cross‐sectional comparison between smokers and non‐smokers
por: Karlsson, Marie‐Louise, et al.
Publicado: (2019)

IgM-Antibodies against Phosphorylcholine in Mothers and Normal or Low Birth Weight Term Newborn Infants
por: Frostegård, Anna G., et al.
Publicado: (2014)

Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study
por: van Wesemael, Tineke J., et al.
Publicado: (2016)

Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations
por: Ajeganova, Sofia, et al.
Publicado: (2017)

Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months
por: Engvall, Inga-Lill, et al.
Publicado: (2010)

Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study
por: Engvall, Inga-Lill, et al.
Publicado: (2008)

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis
por: Andersson, Maria L E, et al.
Publicado: (2013)

IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
por: Thiagarajan, Divya, et al.
Publicado: (2020)

Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study
por: Svensson, Björn, et al.
Publicado: (2014)

Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects
por: Jujić, Amra, et al.
Publicado: (2021)

Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions
por: Samal, Shailesh Kumar, et al.
Publicado: (2022)

Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial
por: Levitsky, Adrian, et al.
Publicado: (2017)

Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality
por: Samal, S. K., et al.
Publicado: (2020)

Autoantibodies in Rheumatoid Arthritis – Laboratory and Clinical Perspectives
por: Rönnelid, Johan, et al.
Publicado: (2021)

Variation in pain related to systemic lupus erythematosus (SLE): a 7-year follow-up study
por: Waldheim, Eva, et al.
Publicado: (2018)

The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis
por: Westerlind, Helga, et al.
Publicado: (2022)

Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms
por: Thiagarajan, D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tc8deep4dm2hokdu1nd8nl8hkp